Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis

…, R Fischer, A Sonnenberg, W Stremmel… - … England Journal of …, 1985 - Mass Medical Soc
We analyzed survival and causes of death among 163 patients with primary hemochromatosis
diagnosed between 1959 and 1983. The mean follow-up period was 10.5±5.6 years (±SD…

Lymphocyte apoptosis induced by CD95 (APO–1/Fas) ligand–expressing tumor cells—a mechanism of immune evasion?

…, M Müller, G Otto, D Strand, SM Mariani, W Stremmel… - Nature medicine, 1996 - nature.com
The CD95 (APO–1/Fas) system is an important mediator of T–cell cytotoxicity. We investigated
this system in 22 hepatocellular carcinomas (HCCs) from patients. All HCCs had partially …

p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs

…, SL Friedman, PR Galle, W Stremmel… - The Journal of …, 1998 - rupress.org
Chemotherapeutic drugs cause DNA damage and kill cancer cells mainly by apoptosis. p53
mediates apoptosis after DNA damage. To explore the pathway of p53-dependent cell death…

Long-term survival in patients with hereditary hemochromatosis

C Niederau, R Fischer, A Purschel, W Stremmel… - Gastroenterology, 1996 - Elsevier
BACKGROUND & AIMS: The course of hereditary hemochromatosis may depend on the
degree of iron overload and the time of therapeutic intervention. This analysis evaluates the …

Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53.

…, H Walczak, WJ Hofmann, W Stremmel… - The Journal of …, 1997 - Am Soc Clin Investig
Chemotherapeutic drugs are cytotoxic by induction of apoptosis in drug-sensitive cells. We
investigated the mechanism of bleomycin-induced cytotoxicity in hepatoma cells. At …

Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage.

…, H Walczak, H Schaller, G Otto, W Stremmel… - The Journal of …, 1995 - rupress.org
Apoptosis occurs in the normal liver and in various forms of liver disease. The CD95 (APO-1/Fas)
(CD95) receptor mediates apoptosis, and liver cells in animal models are acutely …

Clinical presentation, diagnosis and long-term outcome of Wilson's disease: a cohort study

U Merle, M Schaefer, P Ferenci, W Stremmel - Gut, 2007 - gut.bmj.com
Background: Wilson’s disease is a rare inborn disease related to copper storage, leading to
liver cirrhosis and neuropsychological deterioration. Clinical data on larger cohorts are …

Copper in disorders with neurological symptoms: Alzheimer's, Menkes, and Wilson diseases

D Strausak, JFB Mercer, HH Dieter, W Stremmel… - Brain research …, 2001 - Elsevier
Copper is an essential element for the activity of a number of physiologically important
enzymes. Enzyme-related malfunctions may contribute to severe neurological symptoms and …

Acute cholecystitis: early versus delayed cholecystectomy, a multicenter randomized trial (ACDC study, NCT00447304)

…, MR Schön, HK Seitz, D Daniel, W Stremmel… - Annals of …, 2013 - journals.lww.com
Objective: Acute cholecystitis is a common disease, and laparoscopic surgery is the standard
of care. Background: Optimal timing of surgery for acute cholecystitis remains controversial: …

Wilson disease: clinical presentation, treatment, and survival

W Stremmel, KW Meyerrose, C Niederau… - Annals of internal …, 1991 - acpjournals.org
▪ Objective: To evaluate the diagnostic features, clinical course, and overall long-term survival
of patients with Wilson disease. ▪ Design: Retrospective cohort study with a mean follow-…